Aperio Group’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $2.25M | Sell |
91,547
-1,923
| -2% | -$36.1K | 0.01% | 1184 |
|
|
2020
Q3 | $1.52M | Buy |
93,470
+579
| +0.6% | +$10.8K | 0.01% | 1245 |
|
|
2020
Q2 | $1.59M | Buy |
92,891
+4,487
| +5% | +$66.5K | 0.01% | 1210 |
|
|
2020
Q1 | $1.03M | Sell |
88,404
-25,979
| -23% | -$536K | ﹤0.01% | 1291 |
|
|
2019
Q4 | $3.18M | Buy |
114,383
+24,126
| +27% | +$605K | 0.01% | 894 |
|
|
2019
Q3 | $2.04M | Sell |
90,257
-14,178
| -14% | -$323K | 0.01% | 1054 |
|
|
2019
Q2 | $2.63M | Buy |
104,435
+42,838
| +70% | +$1.15M | 0.01% | 939 |
|
|
2019
Q1 | $1.67M | Buy |
61,597
+2,717
| +5% | +$91.1K | 0.01% | 1111 |
|
|
2018
Q4 | $1.94M | Buy |
58,880
+6,011
| +11% | +$242K | 0.01% | 997 |
|
|
2018
Q3 | $2.47M | Sell |
52,869
-3,808
| -7% | -$175K | 0.01% | 957 |
|
|
2018
Q2 | $2.45M | Sell |
56,677
-2,031
| -3% | -$97.3K | 0.01% | 934 |
|
|
2018
Q1 | $3.27M | Sell |
58,708
-269
| -0.5% | -$14.7K | 0.02% | 800 |
|
|
2017
Q4 | $3.15M | Buy |
58,977
+17,289
| +41% | +$816K | 0.02% | 818 |
|
|
2017
Q3 | $1.8M | Buy |
41,688
+18,012
| +76% | +$856K | 0.01% | 976 |
|
|
2017
Q2 | $1.43M | Sell |
23,676
-1,329
| -5% | -$78.8K | 0.01% | 1060 |
|
|
2017
Q1 | $1.73M | Buy |
25,005
+5,394
| +28% | +$375K | 0.01% | 915 |
|
|
2016
Q4 | $1.31M | Sell |
19,611
-2,807
| -13% | -$183K | 0.01% | 999 |
|
|
2016
Q3 | $1.49M | Buy |
22,418
+4,085
| +22% | +$279K | 0.01% | 945 |
|
|
2016
Q2 | $1.33M | Sell |
18,333
-639
| -3% | -$43.9K | 0.01% | 953 |
|
|
2016
Q1 | $1.23M | Buy |
18,972
+3,136
| +20% | +$208K | 0.01% | 959 |
|
|
2015
Q4 | $1.14M | Buy |
15,836
+1,248
| +9% | +$92.3K | 0.01% | 959 |
|
|
2015
Q3 | $1.12M | Buy |
14,588
+957
| +7% | +$77.2K | 0.01% | 935 |
|
|
2015
Q2 | $1.01M | Buy |
13,631
+3,759
| +38% | +$271K | 0.01% | 960 |
|
|
2015
Q1 | $716K | Buy |
9,872
+987
| +11% | +$68.6K | 0.01% | 1086 |
|
|
2014
Q4 | $587K | Buy |
8,885
+40
| +0.5% | +$2.44K | 0.01% | 1146 |
|
|
2014
Q3 | $485K | Buy |
8,845
+753
| +9% | +$42.7K | 0.01% | 1148 |
|
|
2014
Q2 | $471K | Buy |
8,092
+222
| +3% | +$13.1K | 0.01% | 1160 |
|
|
2014
Q1 | $488K | Buy |
+7,870
| New | +$458K | 0.01% | 1343 |
|
|
2013
Q4 | – | Sell |
-6,642
| Closed | -$356K | – | 1399 |
|
|
2013
Q3 | $333K | Buy |
6,642
+914
| +16% | +$44.6K | 0.01% | 1360 |
|
|
2013
Q2 | $262K | Buy |
+5,728
| New | +$256K | 0.01% | 1354 |
|
Other funds holding MD
SV
ACH
PCP
Aperio Group's MD Position: Q4 2020 in Review
Aperio Group reduced its Pediatrix Medical (MD) stake by 2.1% in Q4 2020, selling an estimated $36.1K and leaving 91,547 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #1184.
Aperio Group first reported a position in MD in Q2 2013 and has held it in 30 quarters since. The position peaked at $3.27M in Q1 2018. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.
- Aperio Group held 91,547 shares of Pediatrix Medical worth $2.25M as of Q4 2020.
- Aperio Group sold 1,923 Pediatrix Medical shares in Q4 2020, an estimated $36.1K.
- Pediatrix Medical made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1184 holding.
- Aperio Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Pediatrix Medical position peaked at $3.27M in Q1 2018.
- 201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.